The role of the glyoxalase pathway in reducing mesothelial toxicity of glucose degradation products

Katarzyna Korybalska, Justyna Wisniewska-Elnur, Joanna Trómińska, Achim Jörres, Andrzej Brȩborowicz, Janusz Witowski

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

◆ Background: The glucose degradation products (GDP) presentin conventional peritoneal dialysis fluids (PDF) may exert adverse effects toward human peritoneal mesothelial cells (HPMC). Some GDP can be detoxified by the glyoxalase/glutathione pathway. It has been shown that the addition of glyoxalase I (GLO-I) and reduced glutathione (GSH) to PDF effectively eliminates GDP. We have therefore examined the GLO-I/GSH system in HPMC and assessed the impact of GLO-I/GSH-treated PDF on the viability and function of HPMC. ◆ Methods: Heat-sterilized PDF (H-PDF) was incubated in the presence or absence of GLO-I and GSH for 1 hour at 37°C, and then mixed with an equal volume of serum-free M199 medium and applied to HPMC in culture. After 24 hours, HPMC were assessed for viability, the release of interleukin-6, GLO-I activity, and cellular glutathione. The effects were compared to those exerted by filter-sterilized PDF (F-PDF),which was devoid of GDP. ◆ Results: Exposure of HPMC to H-PDF resulted in reduced GlO-I activity, GSH depletion, and a decrease in cell viability. Pretreatment of H-PDF with either a combination of GLO-I and GSH or GSH alone markedly reduced inhibitory effects of H-PDF toward HPMC, as measured by cell viability and interleukin-6 generation. Exposure of HPMC to the GSH precursor L-2-oxothiazolidine-carboxytic acid increased cellular GSH and prevented the loss of GLO-I activityin response to H-PDF. ◆ Conclusions: Exposure to conventional GOP-rich PDF impairs the activity of the glyoxalase/glutathione system in HPMC. Pretreatment of PDF with GSH or replenishment of cellular GSH protects HPMC against GOP-mediated toxicity.

Original languageEnglish (US)
Pages (from-to)259-265
Number of pages7
JournalPeritoneal Dialysis International
Volume26
Issue number2
StatePublished - Mar 2006
Externally publishedYes

Fingerprint

Lactoylglutathione Lyase
Ascitic Fluid
Peritoneal Dialysis
Glucose
Hot Temperature
Glutathione
Interleukin-6
Cell Survival
Serum-Free Culture Media
Cell Culture Techniques
Acids

Keywords

  • Biocompatibility
  • Dialysis fluids
  • Glucose degradation products
  • Glutathione
  • Glyoxalase
  • Mesothelial cells

ASJC Scopus subject areas

  • Nephrology

Cite this

Korybalska, K., Wisniewska-Elnur, J., Trómińska, J., Jörres, A., Brȩborowicz, A., & Witowski, J. (2006). The role of the glyoxalase pathway in reducing mesothelial toxicity of glucose degradation products. Peritoneal Dialysis International, 26(2), 259-265.

The role of the glyoxalase pathway in reducing mesothelial toxicity of glucose degradation products. / Korybalska, Katarzyna; Wisniewska-Elnur, Justyna; Trómińska, Joanna; Jörres, Achim; Brȩborowicz, Andrzej; Witowski, Janusz.

In: Peritoneal Dialysis International, Vol. 26, No. 2, 03.2006, p. 259-265.

Research output: Contribution to journalArticle

Korybalska, K, Wisniewska-Elnur, J, Trómińska, J, Jörres, A, Brȩborowicz, A & Witowski, J 2006, 'The role of the glyoxalase pathway in reducing mesothelial toxicity of glucose degradation products', Peritoneal Dialysis International, vol. 26, no. 2, pp. 259-265.
Korybalska K, Wisniewska-Elnur J, Trómińska J, Jörres A, Brȩborowicz A, Witowski J. The role of the glyoxalase pathway in reducing mesothelial toxicity of glucose degradation products. Peritoneal Dialysis International. 2006 Mar;26(2):259-265.
Korybalska, Katarzyna ; Wisniewska-Elnur, Justyna ; Trómińska, Joanna ; Jörres, Achim ; Brȩborowicz, Andrzej ; Witowski, Janusz. / The role of the glyoxalase pathway in reducing mesothelial toxicity of glucose degradation products. In: Peritoneal Dialysis International. 2006 ; Vol. 26, No. 2. pp. 259-265.
@article{c3317eaa52294852a005dfc2312341ec,
title = "The role of the glyoxalase pathway in reducing mesothelial toxicity of glucose degradation products",
abstract = "◆ Background: The glucose degradation products (GDP) presentin conventional peritoneal dialysis fluids (PDF) may exert adverse effects toward human peritoneal mesothelial cells (HPMC). Some GDP can be detoxified by the glyoxalase/glutathione pathway. It has been shown that the addition of glyoxalase I (GLO-I) and reduced glutathione (GSH) to PDF effectively eliminates GDP. We have therefore examined the GLO-I/GSH system in HPMC and assessed the impact of GLO-I/GSH-treated PDF on the viability and function of HPMC. ◆ Methods: Heat-sterilized PDF (H-PDF) was incubated in the presence or absence of GLO-I and GSH for 1 hour at 37°C, and then mixed with an equal volume of serum-free M199 medium and applied to HPMC in culture. After 24 hours, HPMC were assessed for viability, the release of interleukin-6, GLO-I activity, and cellular glutathione. The effects were compared to those exerted by filter-sterilized PDF (F-PDF),which was devoid of GDP. ◆ Results: Exposure of HPMC to H-PDF resulted in reduced GlO-I activity, GSH depletion, and a decrease in cell viability. Pretreatment of H-PDF with either a combination of GLO-I and GSH or GSH alone markedly reduced inhibitory effects of H-PDF toward HPMC, as measured by cell viability and interleukin-6 generation. Exposure of HPMC to the GSH precursor L-2-oxothiazolidine-carboxytic acid increased cellular GSH and prevented the loss of GLO-I activityin response to H-PDF. ◆ Conclusions: Exposure to conventional GOP-rich PDF impairs the activity of the glyoxalase/glutathione system in HPMC. Pretreatment of PDF with GSH or replenishment of cellular GSH protects HPMC against GOP-mediated toxicity.",
keywords = "Biocompatibility, Dialysis fluids, Glucose degradation products, Glutathione, Glyoxalase, Mesothelial cells",
author = "Katarzyna Korybalska and Justyna Wisniewska-Elnur and Joanna Tr{\'o}mińska and Achim J{\"o}rres and Andrzej Brȩborowicz and Janusz Witowski",
year = "2006",
month = "3",
language = "English (US)",
volume = "26",
pages = "259--265",
journal = "Peritoneal Dialysis International",
issn = "0896-8608",
publisher = "Multimed Inc.",
number = "2",

}

TY - JOUR

T1 - The role of the glyoxalase pathway in reducing mesothelial toxicity of glucose degradation products

AU - Korybalska, Katarzyna

AU - Wisniewska-Elnur, Justyna

AU - Trómińska, Joanna

AU - Jörres, Achim

AU - Brȩborowicz, Andrzej

AU - Witowski, Janusz

PY - 2006/3

Y1 - 2006/3

N2 - ◆ Background: The glucose degradation products (GDP) presentin conventional peritoneal dialysis fluids (PDF) may exert adverse effects toward human peritoneal mesothelial cells (HPMC). Some GDP can be detoxified by the glyoxalase/glutathione pathway. It has been shown that the addition of glyoxalase I (GLO-I) and reduced glutathione (GSH) to PDF effectively eliminates GDP. We have therefore examined the GLO-I/GSH system in HPMC and assessed the impact of GLO-I/GSH-treated PDF on the viability and function of HPMC. ◆ Methods: Heat-sterilized PDF (H-PDF) was incubated in the presence or absence of GLO-I and GSH for 1 hour at 37°C, and then mixed with an equal volume of serum-free M199 medium and applied to HPMC in culture. After 24 hours, HPMC were assessed for viability, the release of interleukin-6, GLO-I activity, and cellular glutathione. The effects were compared to those exerted by filter-sterilized PDF (F-PDF),which was devoid of GDP. ◆ Results: Exposure of HPMC to H-PDF resulted in reduced GlO-I activity, GSH depletion, and a decrease in cell viability. Pretreatment of H-PDF with either a combination of GLO-I and GSH or GSH alone markedly reduced inhibitory effects of H-PDF toward HPMC, as measured by cell viability and interleukin-6 generation. Exposure of HPMC to the GSH precursor L-2-oxothiazolidine-carboxytic acid increased cellular GSH and prevented the loss of GLO-I activityin response to H-PDF. ◆ Conclusions: Exposure to conventional GOP-rich PDF impairs the activity of the glyoxalase/glutathione system in HPMC. Pretreatment of PDF with GSH or replenishment of cellular GSH protects HPMC against GOP-mediated toxicity.

AB - ◆ Background: The glucose degradation products (GDP) presentin conventional peritoneal dialysis fluids (PDF) may exert adverse effects toward human peritoneal mesothelial cells (HPMC). Some GDP can be detoxified by the glyoxalase/glutathione pathway. It has been shown that the addition of glyoxalase I (GLO-I) and reduced glutathione (GSH) to PDF effectively eliminates GDP. We have therefore examined the GLO-I/GSH system in HPMC and assessed the impact of GLO-I/GSH-treated PDF on the viability and function of HPMC. ◆ Methods: Heat-sterilized PDF (H-PDF) was incubated in the presence or absence of GLO-I and GSH for 1 hour at 37°C, and then mixed with an equal volume of serum-free M199 medium and applied to HPMC in culture. After 24 hours, HPMC were assessed for viability, the release of interleukin-6, GLO-I activity, and cellular glutathione. The effects were compared to those exerted by filter-sterilized PDF (F-PDF),which was devoid of GDP. ◆ Results: Exposure of HPMC to H-PDF resulted in reduced GlO-I activity, GSH depletion, and a decrease in cell viability. Pretreatment of H-PDF with either a combination of GLO-I and GSH or GSH alone markedly reduced inhibitory effects of H-PDF toward HPMC, as measured by cell viability and interleukin-6 generation. Exposure of HPMC to the GSH precursor L-2-oxothiazolidine-carboxytic acid increased cellular GSH and prevented the loss of GLO-I activityin response to H-PDF. ◆ Conclusions: Exposure to conventional GOP-rich PDF impairs the activity of the glyoxalase/glutathione system in HPMC. Pretreatment of PDF with GSH or replenishment of cellular GSH protects HPMC against GOP-mediated toxicity.

KW - Biocompatibility

KW - Dialysis fluids

KW - Glucose degradation products

KW - Glutathione

KW - Glyoxalase

KW - Mesothelial cells

UR - http://www.scopus.com/inward/record.url?scp=33747120699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747120699&partnerID=8YFLogxK

M3 - Article

C2 - 16623434

AN - SCOPUS:33747120699

VL - 26

SP - 259

EP - 265

JO - Peritoneal Dialysis International

JF - Peritoneal Dialysis International

SN - 0896-8608

IS - 2

ER -